ArticleFrontiers in oncology2025
Radiomics-based multiple machine learning approaches for investigating medial wall invasion of the cavernous sinus in pituitary adenomas.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to develop a predictive model for cavernous sinus dural invasion in pituitary adenomas by retrospectively analyzing clinical and imaging data. It explores the associations between clinical and radiomics features and cavernous sinus dural invasion. Methods: Clinical data and coronal T2-weighted MRI images were collected from patients diagnosed with pituitary adenomas at our institution between December 2012 and December 2022. Tumor regions of interest (ROIs) were segmented using 3D Slicer, and radiomics features were extracted. Statistically significant radiomics features were identified using Lasso regression and univariate analysis. Clinical features were screened using univariate and multivariate logistic regression analyses. These selected features were incorporated into ten machine learning algorithms to construct three predictive models: a clinical feature model, a radiomics feature model, and a combined clinical and radiomics feature model. Model performance was evaluated to determine the best-performing model, which was further interpreted. Results: A total of 252 patients with histopathologically confirmed pituitary adenomas were included. The analysis identified Knosp grade, tumor left-right diameter, pedunculated satellite tumor, and clival invasion as significant clinical predictors, along with radiomics features including original.4, original.10, log-sigma-5-0-mm-3D.29, log-sigma-5-0-mm-3D.91, wavelet-LLH.37, wavelet-LHL.37, and wavelet-HLL.8. The combined clinical and radiomics model outperformed models based solely on clinical or radiomics features. Among the ten machine learning algorithms, the LightGBM model demonstrated the best predictive performance, achieving an area under the curve (AUC) of 0.86 and an accuracy (ACC) of 0.76. Conclusions: A machine learning model integrating clinical and radiomics features can effectively predict cavernous sinus dural invasion in pituitary adenomas preoperatively, providing a reliable basis for diagnosing tumor invasiveness and developing surgical plans. The LightGBM algorithm exhibited the highest predictive efficacy. Furthermore, the pedunculated satellite tumor feature emerged as a novel imaging marker for cavernous sinus dural invasion, offering new insights into the study of invasive pituitary adenomas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.